Healthcare IT News February 5, 2024
Novii+ allows for continuous monitoring of high-risk pregnancies after 34 weeks, and alerts care teams of heart rate and contraction patterns during labor.
GE HealthCare received FDA 510(k) clearance for its Novii+ maternal and fetal monitoring solution, which will become available to U.S. customers later in the year.
The device, consisting of a wearable and wireless sensor, enables noninvasive measurement and display of fetal heart rate, maternal heart rate and uterine activity for pregnant patients at or beyond 34 weeks.
With the expanded indication granted by the FDA, Novii+, care teams can now use the monitoring solution for a more significant number of patients faced with high-risk pregnancies.
Novii+ offers a personalized view of the mother’s and fetus’s statuses...
Today's Sponsors
Today's Sponsor